Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

September 16, 2021

Study Completion Date

September 16, 2021

Conditions

Pain

Interventions

DRUG

Placebo

Placebo will be available as intravenous (IV) infusion of normal saline (0.9 percent \[%\] sodium chloride solution).

DRUG

GSK3858279

GSK3858279 will be available as IV infusion and the dose level to be administered is 3 milligrams (mg) per kilogram (kg).

Trial Locations (1)

GSK Investigational Site, Leiden